Poster & Exhibitor Reception

F.1

Effects of Aryl Hydrocarbon Receptor Activation on Pulmonary Innate Lymphoid Cells and Dendritic Cells.
David Shepherd, PhD, University of Montana; Joanna Kreitinger, BS, University of Montana; Benjamin Seaver, BS, University of Montana; Caroline Andrews, DVM, National Cancer Institute; Scott Durum, PhD, National Cancer Institute; Celine Beamer, PhD, University of Montana

F.2

IL-33 AND TSLP MEDIATE STEROID-RESISTANT AIRWAY INFLAMMATION IN MICE
Homayon Banie, Janssen-J&J

F.3

Absence of Endothelial MAdCAM-1 in Nkx2.3^-/- Mice Leads to Accumulation of Solitary Intestinal Lymphoid Tissue With Immature Phenotype.
Zoltan Kellermayer, MD, University of Pecs; Peter Balogh, MD, PhD, University of Pecs

F.4

Dietary plasma protein supplementation ameliorates intestinal inflammation in a mice model of double challenge inflammation
Anna Perez-Bosque, PhD, Faculty of Pharmacy (University of Barcelona); Lluisa Miro, PhD, APC-Europe, SA; Javier Polo, PhD, APC-Europe, SA; Miquel MoretÃ³, Prof., Faculty of Pharmacy (University of Barcelona)

F.5

Elevated Endoplasmic Reticulum Stress Reinforced Immunosuppression in the Tumor Microenvironment via Myeloid-Derived Suppressor Cells
Bo-Eun Kwon, Kangwon National University; Eun Hye Hong, Kangwon national university; Hyun-jeong Ko, Kangwon National University

F.6

Antinflammatory Effect of the Recombinant Calreticulin from Taenia solium on Human Cells
Laura DÃaz Alvarez, MSc, Posgrado en Ciencias BiolÃ³gicas, UNAM; Fela Mendlovic, MSc, Universidad Nacional Autonoma de Mexico; Ana Flisser, PhD, Universidad Nacional Autonoma de Mexico

F.7

Critical Role of MyD88 in Phagocytosis and Cell Signaling During E. faecalis Infection of Macrophages
Nathan Shankar, PhD, University of Oklahoma HSC; Jun Zou, DVM, PhD, University of Oklahoma HSC

F.8

Identification of Factors Guiding Monocyte Differentiation Towards Distinct Resident Macrophage Fates in the Small and Large Intestine
Mor Gross, Weizmann Institute of Science; Biana Bernshtein, Weizmann Institute of Science; Eyal David, Weizmann Institute of Science; Steffen Jung, Weizmann Institute of Science

F.9

IL-10 Rapidly Inhibits Transcription of Secondary Response Genes in LPS-Stimulated Macrophages
Bruce Horwitz, Brigham and Women's Hospital; Evan Conaway, Brigham and Women's Hospital

F.10

Loss of myeloid hypoxia inducible factor-1 ameliorates dextran sodium sulfate induced colitis in mice
Veronika Reichmann, Institute of Physiology; Sandra Winning, Institut für Physiologie, Universität Duisburg-Essen; Joachim Fandrey, Institut für Physiologie, Universität Duisburg-Essen

F.11

DIFFERENTIAL REGULATION of INTESTINAL MACROPHAGE FUNCTION by INTERLEUKIN-10 and the GUT MICROBIOTA in the COLON versus the SMALL-BOWEL
Elizabeth Mann, PhD, Johns Hopkins University; Peter Andersen, PhD, Johns Hopkins University; Dezhi Wang, MD, Johns Hopkins University; Ying Dong, MD, PhD, Johns Hopkins University; Weiwei Jiang, MD, Johns Hopkins University; James Foster, PhD, Johns Hopkins University; Daniel Peterson, PhD, Johns Hopkins University; Xuhang Li, PhD, Johns Hopkins University

F.12

Chemokine Property Of MIF Favors Immunosurveillance In Murine Colorectal Cancer
Miriam Rodriguez-Sosa, Facultad de estudios superiores-Iztacala, UNAM; Thalia Pacheco-Fernández, Facultad de estudios superiores-Iztacala, UNAM; Luis Ignacio Terrazas-Valdés, PhD, Facultad de estudios superiores-Iztacala, UNAM; Imelda Juarez-Avelar, MSc, Facultad de estudios superiores-Iztacala, UNAM

F.13

Identification of potential therapeutic macrophage-related targets for inflammatory bowel disease (IBD)
Francesca Ammoscato, Barts and The London School of Medine and Dentistry; Aneta Kucik, Barts and The London School of Medicine and Dentistry; Paolo Biancheri, MD, Barts and The London School of Medicine and Dentistry; Paolo Giuffrida, Clinica Medica I Laboratorio di Gastroenterologia Fondazione IRCCS Policlinico San Matteo; Laurens Kruidenier, PhD, Takeda Cambridge Limited; Thomas MacDonald, PhD, Barts and the London School of Medicine and Dentistry

F.14

Post-transcriptional control of inflammasome activation in intestinal macrophages
Alessandra Filardy, PhD, National Institutes of Health; JianPing He, PhD, Mucosal Immunobiology Section, Laboratory of Molecular Immunology, NIAID, NIH; Mina Seedhom, PhD, Cellular Biology and Viral Immunology Sections, Laboratory of Viral Diseases, NIAID, NIH; Jack Bennink, PhD, Cellular Biology and Viral Immunology Sections, Laboratory of Viral Diseases, NIAID, NIH; John Yewdell, MD, PhD, Cellular Biology and Viral Immunology Sections, Laboratory of Viral Diseases, NIAID, NIH; Brian Kelsall, MD, Mucosal Immunobiology Section, Laboratory of Molecular Immunology, NIAID, NIH

F.15

HDAC5: a New Player in Macrophage Activation and Intestinal Homeostasis
Marie Sittig, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology; Jacqueline Keye, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology; Lukas Poralla, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology; Michael Schumann, MD, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology; Ulrike Erben, PhD, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology; Rainer Glauben, PhD, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology; Britta Siegmund, MD, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology

F.16

Precise identification and functional characterisation of human intestinal macrophages in health and disease
Pamela Wright, Institute of Infection, Immunity and Inflammation, University of Glasgow; Calum Bain, MRC Centre for Inflammation Research, University of Edinburgh; Allan Mowat, MD, PhD, University of Glasgow; Daniel Gaya, Inflammatory Bowel Diseases Service, Gastroenterology Unit, Glasgow Royal Infirmary; Simon Milling, PhD, Institute of Infection, Immunity and Inflammation, University of Glasgow

F.17

INNATE and ADAPTATIVE IMMUNE FUNCTIONS of PEYER'S PATCH MONOCYTE-DERIVED CELLS
Johnny Bonnardel, CIML; Clément Da Silva, CIML; Jean-Pierre Gorvel, CIML; Hugues Lelouard, CNRS

F.18

The Role of Free Fatty Acid on Modulating Regulatory Phenotype of MDSC
Wu Hao, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology; Rainer Glauben, PhD, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology; Qin Zhihai, PhD, Institute of Biophysics, Chinese Academy of Science; Britta Siegmund, MD, Charité - Universitätsmedizin Berlin, Department of Gastroenterology, Infectiology and Rheumatology

F.19

Interaction between enteric glia and immune cells as new players in intestinal homeostasis
Gera Goverse, VUmc; Pedro J. Gomez-Pinilla, Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium; Evelien Labeeuw, Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium; Giovanna Farro, Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium; Guy Boeckxstaens, Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium; Gianluca Matteoli, Dr., Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium

F.20

Homeostatic Functions of Intestinal Macrophages
Ashok Kumawat, Institute of Infection, Immunity and Inflammation; College of Medical, Veterinary and Life Sciences; University of Glasgow, Sir Graeme Davies Building,; Calum Bain, MRC Centre for Inflammation Research, University of Edinburgh; Silvia Finnemann, PhD, Fordham University; Allan Mowat, MD, PhD, University of Glasgow

F.21

Potentiation of IL-4 and Vitamin D3 Receptor Signaling by Retinoic Acid in Intestinal Epithelial Cells and Macrophages - Mechanisms and Targets
Harry Dawson, Ph.D., ARS/USDA; Celine Chen, Ph.D., ARS/USDA; Joseph Urban Jr., Ph.D., ARS/USDA; Sandra Heibel, Ph.D., ARS/USDA

F.22

The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting Natural killer cell tumoricidal activity
Maya Saleh, PhD, McGill University

F.23

Oral Challenge with Wild-type Salmonella Typhi Induces Distinct Changes in B cell Subsets in Individuals Who Develop Typhoid Disease
Franklin Toapanta, CVD - University of Maryland - Baltimore; Paula Bernal, University of Maryland Baltimore; Stephanie Fresnay, Center for Vaccine Development, University of Maryland School of Medicine; Thomas Darton, Oxford Vaccine Group, University of Oxford; Claire Jones, Oxford Vaccine Group, University of Oxford; Claire Waddington, Oxford Vaccine Group, University of Oxford; Christoph Blohmke, Oxford Vaccine Group, University of Oxford; Gordon Dougan, Microbial Pathogenesis Group, Wellcome Trust Sanger Institute; Brian Angus, Nuffield Department of Medicine, University of Oxford; Myron Levine, Center for Vaccine Development, University of Maryland School of Medicine; Andrew Pollard, Oxford Vaccine Group, University of Oxford; Marcelo Sztein, Center for Vaccine Development, University of Maryland School of Medicine

F.25

Early-treatment of HIV-infected patients favours the preservation and the development of HIV-specific B cells as well as TFH cells in the gastrointestinal mucosa
Cyril Planchais, PhD, INSERM; Laurent Hocqueloux, MD, CHR d'Orléans - La Source; Ayrin Kök, PhD, Institut Pasteur; Nicolas Ruffin, PhD, Inserm U932, Institut Curie; Thierry Prazuck, MD, CHR d'Orléans - La Source; Laurent Lefrou, MD, Department of Hepato-Gastro-Enterology, CHR d'Orléans-La Source; Nabila Seddiki, PhD, INSERM U955, Team 16, Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine; Jean-Daniel Lelièvre, PU-PH, INSERM U955, Team 16, Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine; Yves Lévy, PU-PH, INSERM U955, Team 16, Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine; Hugo Mouquet, PhD, Institut Pasteur; Sophie Hüe, PU-PH, INSERM U955, Team 16, Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine

F.26

IgD Activates an Ancestral Galectin-9-CD44-Dependent Protective Pathway That Uncouples Th2 Immunity From Th2 Inflammation
Meimei Shan, Mount Sinai School of Medicine; Cooper Walland, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Jorge Carrillo, Ph D, IrsiCaixa Institute for AIDS Research, Badalona, 08916 Spain; John Yeiser, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Kang Chen, Ph D, Wayne State University; Andrea Cerutti, MD, PhD, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

F.27

Marginal zone B cells in human gut-associated lymphoid tissue
Jo Spencer, PhD, King's College London; Yuan Zhao, PhD, King's College London; Mohamed Uduman, PhD, Yale School of Medicine; Yu-Chang (Bryan) Wu, PhD, King's College London; Wayel Jassem, PhD, King's College London; Konstantia-Maria Chavele, PhD, King's College London; Andrew Wotherspoon, FRCPath, Royal Marsden Hospital; Jeremy Sanderson, MD, King's College London; Mats Bemark, PhD, University of Gothenburg; Steven Kleinstein, PhD, Yale School of Medicine

F.28

Development of the Respiratory Polymeric Immunoglobulin Secretory Immune System (PISIS) in a Porcine Model
Marco Vega-Lopez, PhD, Centro de Investigacion y de Estudios Avanzados del IPN, Mexico; Edgar Guzman-Bautista, MSc, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Infectómica y Patogénesis Molecular, Laboratorio de Inmunobiología de las Mucosas. mavega@cinvestav.mx; Carmen Ramirez-Estudillo, BSc., Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Infectómica y Patogénesis Molecular, Laboratorio de Inmunobiología de las Mucosas. mavega@cinvestav.mx; Oscar Rojas, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Infectómica y Patogénesis Molecular, Laboratorio de Inmunobiología de las Mucosas. mavega@cinvestav.mx

F.29

Dysbiosis-Associated Mortality During Dextran Sulfate Sodium (DSS) Induced Murine Colitis is Reduced by 2’-fucosyllactose, a Human Milk Oligosaccharide
YingYing He, MD, PhD, The Biology department, Boston College; David Hill, PhD, University of Michigan Medical Center; Paul McCabe, boston college; David Newburg, PhD, Boston College

F.30

Modulation of CD14 Expression in Human Enterocytes by the Human Milk Oligosaccharide 2’-fucosyllactose Attenuates Type 1 Pili LPS-Mediated Inﬂammation
YingYing He, MD, PhD, The Biology department, Boston College; Shubai Liu, PhD, Brigham and Women's Hospital; David Kling, PhD, boston college; Serena Leone, PhD, University of Naples "Frederico II"; Nathan Lawlor, boston college; Yi Huang, MD, Boston College; Samuel Feinberg, boston college; David Hill, PhD, University of Michigan Medical Center; David Newburg, PhD, Boston College

F.31

Active suppression of intestinal CD4⁺TCRαβ⁺ T lymphocyte maturation during the postnatal period
Natalia Torow, RWTH Aachen; Kai Yu, Hannover Medical School; Jenny Freitag, TWINCORE; Kasra Hassani, Hannover Medical School; Matthias Lochner, Twincore, Centre for Experimantal and Clinical Infection Research; Andé Bleich, Hannover Medical School, Institute for Laboratory Animal Science; Tim Sparwasser, TWINCORE; Reinhold Förster, Hannover Medical School; Oliver Pabst, MD, Institute of Molecular Medicine, Uniklinik RWTH Aachen; Mathias Hornef, MD, RWTH Aachen

F.32

Dendritic cell Development in the Neonatal Intestine
Tamsin Zangerle Murray, University of Glasgow; Calum Bain, MRC Centre for Inflammation Research, University of Edinburgh; Allan Mowat, MD, PhD, University of Glasgow

F.33

MATURATION of the AVIAN IgA SYSTEM CRITICALLY DEPENDS on MICROBIAL COLONIZATION
Bernd Kaspers, DVM, PhD, University of Munich; Sarah Lettmann, DVM, University of Munich; Susanne Röll, DVM, University of Munich; Philippe Velge, PhD, French National Institute for Agricultural Research; Catherine Schouler, PhD, French National Institute for Agricultural Research

F.34

Mice with Neural Crest Conditional Deletion of EdnrB Model Neonatal Hirschsprung’s Associated Enterocolitis
Ankush Gosain, University of Wisconsin; Amanda Barlow-Anacker, PhD, University of Wisconsin; Ken Kudsk, MD, University of Wisconsin; Miles Epstein, PhD, University of Wisconsin

F.35

Prophylactic Interleukin-2 Treatment Prevents Fetal Gut Inflammation and Injury in an Ovine Model of Chorioamnionitis
Maria Nikiforou, MSc, Department of Pediatrics, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands; Joris Vanderlocht, PhD, School of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands; Boris Kramer, MD, PhD, School of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands; Tim Wolfs, PhD, School of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands

F.36

The Immune Response Against Chlamydia Suis Genital Tract Infection Partially Protects Against Re-Infection
Daisy Vanrompay, DVM, PhD, Lab of Immunology and Animal Biotechnology, Ghent University; Evelien De Clercq, Ghent University; Bert Devriendt, PhD, University of Ghent; Yin Lizi, Sichuan Agricultural University; Koen Chiers, Ghent University; Wim Van den Broeck, Ghent University; Eric Cox, DVM, PhD, Lab of Immunology, Ghent University

F.37

Elucidating Pathways of Toxoplasma gondii Infection in the Gastrointestinal Tract: Involvement of the Tight Junction Protein Occludin
Caroline Weight, PhD, Lund University; Emily Jones, BSc, Institute of Food Research; Nikki Horn, BSc, Institute of Food Research; Nikolaus Wellner, PhD, Institute of Food Research; Simon Carding, Institute of Food Research

F.38

Mechanism for Persistent Salmonella enterica serovar Enteritidis Infections in Chickens: Induction of Anti-Inflammatory Host Cell Signaling and the Migration and Activation of T Regulatory T Cells
Michael Kogut, USDA-ARS; Ryan Arsenault, PhD, USDA-ARS; Christina Swaggerty, PhD, USDA-ARS; Ramesh Selvaraj, PhD, The Ohio State University

F.39

Regulation of Type 2 Diabetes by Helminth-Induced Th2 Immune Responses
Motoko Morimoto, Miyagi University; Noritsugu Azuma, Miyagi University; Tatsuya Abe, Miyagi University; Yoshiko Suto, Miyagi University

F.40

Prior Cryptosporidium Infection Leads to Protective Th-1 Type Mucosal Immunity Despite Protein Malnutrition
Luther Bartelt, University of Virginia; David Bolick, University of Virginia; Glynis Killing, PhD, University of Virginia; Edna Zaenker, University of Virginia; John Moore, University of Virginia; Cirle Warren, MD, University of Virginia; Richard Guerrant, MD, University of Virginia

F.41

Secretory IgA Deficiency In Small Airways Results In COPD-Like Lung Inflammation And Remodeling
Vasiliy Polosukhin, MD, PhD, Vanderbilt University School of Medicine; Bradley W. Richmond, MD, Vanderbilt University School of Medicine; Timothy S. Blackwell, MD, Vanderbilt University School of Medicine

F.42

Helminth-based Therapy of Colitis – Influence on Tumor Growth and Progression in Colitis-associated Colon Cancer
Eva Pastille, PhD, University Hospital Essen; Alexandra Adamczyk, University Hospital Essen; Astrid M. Westendorf, PhD, University Hospital Essen; Rick M. Maizels, PhD, University of Edinburgh, Institute of Immunology and Infection Research; Henry J. McSorley, PhD, University of Edinburgh, Institute of Immunology and Infection Research

F.43

Disease in the Absence of Virulence Factors: "Avirulent" (TTSS-1/2-deficient) Salmonella Mutants Induce Colitis in NADPH Oxidase KO-Mice
Boas Felmy, ETH Zurich; Pascal Songhet, PhD, Institute of Microbiology, D-BIOL, ETH Zurich; Mathias Heikenwälder, PhD, Institute for Virology, Technical University Munich/Helmholtz Center Munich; Jean-Claude Sirard, PhD, Centre d’Infection et d’Immunité de Lille, Institut Pasteur de Lille; Wolf-Dietrich Hardt, Institute of Microbiology, D-BIOL, ETH Zurich

F.44

Constitutive, intestinal IgA secretion is regulated by NLRP3-derived IL-1 and confers protection from enterotoxin-induced fluid accumulation
Craig McEntee, Trinity College Dublin; Rachel McLoughlin, Trinity College Dublin; Ed Lavelle, Trinity College Dublin

F.45

IL-18 -a Key Modulator of Mucosal Inflammation during Salmonella Infection
Anna A. Mueller, Institute of Microbiology, D-BIOL, ETH Zurich; Tamas Dolowschiak, ETH Zurich; Mikael E. Sellin, PhD, Institute of Microbiology, D-BIOL, ETH Zurich; Wolf-Dietrich Hardt, Institute of Microbiology, D-BIOL, ETH Zurich

F.46

Elmo-1 Regulates the Induction of Autophagy and Bacterial Clearance During Salmonella Infection
Arup Sarkar, Trident Academy of Creatve Technology; Courtney Lyons, University of California, San Diego; Sarah Fox, University of California, San Diego; Thaddeus Stappenbeck, Washington University in St. Louis; Soumita Das, University of California, San Diego; Peter Ernst, University of California, San Diego

F.47

Interleukin-1 Signaling in Intestinal Stromal Cells Prevents Bacteremia upon Citrobacter rodentium Infection via Migration of IL-22 Secreting Neutrophils at Early Stages of Infection
Yong-Soo Lee, University of Ulsan College of Medicine/Asan Medical Center; Jin-Young Yang, University of Ulsan College of Medicine/Asan Medical Center; Yeji Kim, University of Ulsan College of Medicine/Asan Medical Center; Su-Hyun Lee, University of Ulsan College of Medicine/Asan Medical Center; Mi-Na Kweon, Ph.D, University of Ulsan College of Medicine/Asan Medical Center

F.48

Toll-like receptor 5 Agonist Improves the Therapeutic Efficacy of Antibiotic Treatments of Primary and Post-influenza Pneumococcal Infections
RÃ©mi Porte, Team 8 - Center of Infection and Immunity of Lille; Jean-Claude Sirard, PhD, Centre National de la Recherche Scientifique, UMR 8204; Nathalia Muñoz, Laboratory for Vaccine Research, Department of Biotechnology, Instituto de Higiene, Facultad de Medicina, Universidad de la Republica; Delphine Fougeron, PhD, Institut National de la Santé et de la Recherche Médicale, U1019; Anne-France Georgel, Université de Lille; Julien Tabareau, Université de Lille; Frederic Wallet, PhD, Laboratoire de Bactériologie Hygiène, Institut de Microbiologie, Centre de Biologie Pathologie, CHRU Lille; Jose Chabalgoity, PhD, Laboratory for Vaccine Research, Department of Biotechnology, Instituto de Higiene, Facultad de Medicina, Universidad de la Republica; Christophe Carnoy, PhD, Université de Lille; François Trottein, PhD, Université de Lille; Christophe Paget, PhD, Université de Lille

F.49

IL-22 plays a key-role in nontypeable Haemophilus influenzae clearance in Chronic Obstructive Pulmonary Disease
Magdiel Perez-Cruz, PhD, Université Lille Nord de France; Riti Sharan, PhD, CNRS-UMR8204; Gwenola Kervoaze, MD, CNRS-UMR8204; Muriel Pichavant, PhD, CNRS-UMR8204; Philippe Gosset, PhD, INSERM U1019- CNRS UMR8024- Institut Pasteur de Lille

F.50

Characterization of Mast cell in inflamed gingiva in mouse model.
Ryoki Kobayashi, DDS, PhD, Dept of Oral Immunology NUSDM; Kohtaro Fujihashi, DDS, PhD, Department of Pediatric Dentistry, University of Alabama at Birmingham; Tomoko Ochiai, PhD, Department of Oral Immunology, Nihon University School of Dentistry at Matsudo

F.51

Mucosal Associated Invariant T cells (MAIT) in the human gastric mucosa and blood: Role in Helicobacter pylori infection
Jayaum S Booth, Center for Vaccine Development, University of Maryland School of Medicine; Rosangela Salerno-Goncalves, Center for Vaccine Development, University of Maryland School of Medicine; Thomas G. Blanchard, Department of Pediatrics, University of Maryland School of Medicine; Seema Patil, Division of Gastroenterology and Hepatology, University of Maryland School of Medicine; Howard A. Kader, Department of Pediatrics, University of Maryland School of Medicine; Anca M. Safta, Department of Pediatrics, University of Maryland School of Medicine; Lindsay M. Morningstar, Department of Pediatrics, University of Maryland School of Medicine; Steven J. Czinn, Department of Pediatrics, University of Maryland School of Medicine; Bruce D. Greenwald, Division of Gastroenterology and Hepatology, University of Maryland School of Medicine; Marcelo Sztein, Department of Medicine, University of Maryland School of Medicine

F.52

Intestinal barrier dysfunction during Whipple’s disease
Julian Friebel, Charité - CBF, medical clinic for cardiology; Verena Moos, PhD, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin; Katina Schinnerling, Programa Disciplinario de Inmunología, Facultad de Medicina, Universidad de Chile; Anika Geelhaar-Karsch, Charite - CBF, medical clinic I; Kristina Allers, PhD, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin; Sabrina Janßen, Charite - CBF, medical clinic I; Kathleen Weigt, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin; Laura Neumann, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin; Thomas Schneider, MD, PhD, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin

F.53

The Mucin Muc1 Suppresses Helicobacter pylori-induced Gastritis by Regulating the NLRP3 Inflammasome
Poshmaal Dhar, University of Melbourne; Garrett Ng, Dr, Murdoch Childrens Research Institute; Michael McGuckin, PhD, Immunity, Infection and Inflammation Program, Mater Research Institute - The University of Queensland, Translational Research Institute; Philip Sutton, Murdoch Children's Research Institute

F.54

Mapping the cellular source and role of IL-22 in murine lung infections
Maximilian Plank, University of Newcastle; Gerard Kaiko, Washington University St Louis; Steven Maltby, University of Newcastle; Hock Tay, PhD, The University of Newcastle; Jessica Stewart, University of Newcastle; Scott Durum, PhD, National Cancer Institute; Paul Foster, PhD, The University of Newcastle

F.55

Atrophy of Jejunal Peyer´s Patches (JPP) as a Consequence of Experimental Infection of Goats with Mycobacterium avium subsp. paratuberculosis (MAP)
Elizabeth Liebler-Tenorio, Federal Research Institute for Animal Health; Jan Schinkoethe, Federal Research Institute for Animal Health; Heike Koehler, Federal Research Institute for Animal Health

F.57

Fungus-reactive T cells as Sensitive and Specific Sensors to Diagnose Fungal Infections in Cystic Fibrosis Patients
Petra Bacher, 1Department of Cellular Immunology Charité - Universitätsmedizin Berlin; Olaf Kniemeyer, Hans Knoell Institute (HKI) Jena and Institute of Microbiology, Friedrich Schiller University Jena; Ernst Rietschel, Children´s Hospital, University of Cologne; Angela Steinbach, University Hospital of Cologne; Oliver Cornely, University Hospital of Cologne; Axel Brakhage, Hans Knoell Institute (HKI) Jena and Institute of Microbiology, Friedrich Schiller University Jena; Carsten Schwarz, CharitÃ©-UniversitÃ¤tsmedizin Berlin; Alexander Scheffold, Charité University Hospital, Department of Rheumatology and Clinical Immunology

F.58

REDUCED INTESTINAL PRODUCTION OF CCL20 DURING CRYPTOSPORIDIOSIS IN NEONATAL MICE: A MECHANISM BY WHICH CRYPTOSPORIDIUM PARVUM ESCAPES ANTIMICROBIAL ACTIVITY OF CCL20 ?
William Guesdon, PhD, INRA; Gaël Auray, PhD, INRA; Francoise Bussière, PhD, INRA; Laurent Potiron, PhD student, INRA; Fabrice Laurent, PhD, INRA; Sonia Lacroix-Lamande, PhD, INRA

F.59

Murine Norovirus Exacerbates Intestinal Inflammation in IL10-deficient Mice Colonized with Defined Flora
Marijana Basic, Hannover Medical School, Institute for Laboratory Animal Science; Manuela Buettner, Hannover Medical School, Institute for Laboratory Animal Science; Lydia Keubler, PhD, Institute of Laboratory Animal Science; Anna Smoczek, Hannover medical school, Institute of Laboratory Animal Science; André Bleich, Hannover Medical School, Institute for Laboratory Animal Science

F.60

Resident memory γδ T cells orchestrate response to secondary oral Lm infection
Pablo Romagnoli, UConn Health Center; Brian Sheridan, PhD, Stony Brook Universit; Quynh-Mai Pham, UConn Health Center; Leo Lefrancois, PhD, UConn Health Center; Kamal Khanna, PhD, UConn Health Center

F.61

Early events of rectal transmission of Simian Immunodeficiency Virus
Qingsheng Li, Nebraska Center for Virology and School of Biological Sciences, University of Nebraska-Lincoln; Qingsheng Li, Ph. D, School of Biological Science and Nebraska Center for Virology, University of Nebraska

F.62

The Effects of Salmonella typhimurium on Intestinal Dendritic Cells
Alberto Bravo-Blas, PhD, Centre for Immunobiology, Institute of Infection, Immunity and Inflammation; Lotta Utrianien, PhD, Centre for Immunobiology, Institute of Infection, Immunity and Inflammation; Dónal M. Wall, PhD, Centre for Immunobiology, Institute of Infection, Immunity and Inflammation; Simon W. F. Milling, PhD, Centre for Immunobiology, Institute of Infection, Immunity and Inflammation

F.63

ORAL ENTEROPATHOGENIC E. coli (EPEC) INFECTION of NEWBORN MICE
Aline Dupont, Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School; Yael Litvak, Institute for Microbiology and Molecular Genetics, Faculty of Medicine, The Hebrew University of Jerusalem; Kaiyi Zhang, Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School; Felix Sommer, Department of Molecular and Clinical Medicine, University of Gothenburg; Marcus Fulde, Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School; Ilan Rosenshine, Institute for Microbiology and Molecular Genetics, Faculty of Medicine, The Hebrew University of Jerusalem; Mathias W Hornef, Institute for Medical Microbiology, University Hospital RWTH Aachen

F.64

Identification and characterization of the “GUT VASCULAR BARRIER” that is exploited by Salmonella typhimurium for its systemic dissemination
Ilaria Spadoni, PhD, European Institute of Oncology; Elena Zagato, PhD, European Institute of Oncology; Alice Bertocchi, European Institute of Oncology; Roberta Paolinelli, PhD, 2IFOM, FIRC Institute of Molecular Oncology; Antonio Di Sabatino, MD, 3First Department of Medicine, St. Matteo Hospital, University of Pavia; Flavio Caprioli, MD PhD, Ospedale Maggiore Policlinico di Milano; Luca Bottiglieri, MD, European Institute of Oncology; Amanda Oldani, PhD, IFOM, FIRC Institute of Molecular Oncology; Giuseppe Viale, MD, European Institute of Oncology; Giuseppe Penna, European Institute of Oncology; Elisabetta Dejana, PhD, IFOM, FIRC Institute of Molecular Oncology; Maria Rescigno, Prof, European Institute of Oncology

F.65

Herpes simplex virus (HSV) suppressive therapy in HSV-2/HIV-1 co-infected women is associated with reduced markers of inflammation in the systemic but not the mucosal compartment
Erica Andersen-Nissen, Cape Town HVTN Immunology Laboratory; Joanne T. Chang, University of Michigan; Katherine K. Thomas, University of Washington; Devin J. Adams, Fred Hutchinson Cancer Research Center; Connie Celum, University of Washington; Jorge Sanchez, Investigaciones Medicas en Salud; Deborah Donnell, Fred Hutchinson Cancer Research Center; M. Juliana McElrath, University of Washington; Jared M. Baeten, University of Washington

F.66

Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through Id2−dependent Regulation of Microbiota
Xiaohuan Guo, Tsinghua University; Yong Liang, University of Chicago; Barbara Kee, University of Chicago; Yuan Zhang, University of Chicago; Anna Lasorella, Columbia University Medical Center; Yang-Xin Fu, University of Chicago

F.67

Mucosal Associated Invariant T (MAIT) Cells are Highly Activated in Duodenal Tissue of Humans with Vibrio cholerae Infection
M. Arifur Rahman, MSc, International Centre for Diarrhoeal Disease Research, Bangladesh; Mohammad Rubel Hoq, MSc, International Centre for Diarrhoeal Disease Research, Bangladesh; Rasheduzzaman Rashu, MSc, International Centre for Diarrhoeal Disease Research, Bangladesh; Mohammad Ikhtear Uddin, MSc, International Centre for Diarrhoeal Disease Research, Bangladesh; Amena Aktar, MSc, International Centre for Diarrhoeal Disease Research, Bangladesh; Ashraful Khan, MBBS, PhD, International Centre for Diarrhoeal Disease Research, Bangladesh; Fahima Chowdhury, MBBS, International Centre for Diarrhoeal Disease Research, Bangladesh; Taufiqur Bhuiyan, PhD, International Centre for Diarrhoeal Disease Research, Bangladesh; Jason Harris, MD, Massachusetts General Hospital; Stephen Calderwood, MD, Massachusetts General Hospital; Edward Ryan, MD, Massachusetts General Hospital; Firdausi Qadri, PhD, International Centre for Diarrhoeal Disease Research, Bangladesh; Daniel Leung, MD, MSc, University of Utah

F.68

Dysbiosis Associated with Intestinal Pathology in Mice Infected with Malaria Parasites
Tomoyo Taniguchi, Gunma University; Eiji Miyauchi, RIKEN Center for Integrative Medical Sciences; Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences; Hajime Hisaeda, Department of Parasitology, Graduate School of Medicine, Gunma University

F.69

Male IgG Seroconversion to Urogenital Chlamydial Infection Exacerbates Immunopathology in Females
Charles Armitage, PhD, Queensland University of Technology; Connor O'Meara, PhD, Max Planck Institute for Immunobiology and Epigenetics; Richard S Blumberg, MD PhD, Division of Gastroenterology and Hepatology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School; Kenneth Beagley, PhD, Queensland Univ of Technology

F.70

The human cytomegalovirus glycoprotein UL16 selectively mediates intracellular sequestration of the MHC class I-related neonatal Fc receptor (FcRn) for IgG
Xiaoping Zhu, University of Maryland; Jin Tang, University of Maryland; Xiaoyang Liu, University of Maryland; Senthilkumar Palaniyandi, University of Maryland; Weizhong Li, University of Maryland; Susan Park Ochsner, University of Maryland; Kyle Todd, University of Maryland; Sunil Khattar, University of Maryland; Ruiping She, China Agricultural University; Siba Samal, University of Maryland; C. David Pauza, Institute of Human Virology, University of Maryland School of Medicine; Xun Suo, China Agricultural University

F.71

CLEAREANCE OF PTX3 PRE-OPSONIZED CONIDIA OF A. FUMIGATUS FROM THE LUNG OF RATS IMMUNOSUPPRESSED BY CORTISONE ACETATE
Giovanni Salvatori, Sigma-Tau S.p.A.

F.72

Mucosal iNOS-producing IgA⁺ Plasma Cells in Helicobacter pylori-infected Patients
Laura Neumann, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin; Mattea Müller, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin; Verena Moos, PhD, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin; Kathleen Weigt, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin; Kristina Allers, PhD, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin; Anton Aebischer, Robert Koch Institute; Ralf Ignatius, Institute for Microbiology and Hygiene, Charité-Universitätsmedizin Berlin; Thomas Schneider, MD, PhD, Department of Gastroenterology, Infectious Diseases, and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin

F.73

Role of Mucosal Associated Invariant T cells in Helicobacter infection
Criselle Dsouza, The University of Melbourne; Zhenjun Chen, The University of Melbourne; Alexandra Corbett, **, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity; Alison Every, The University of Melbourne; Jean-Pierre Scheerlinck, The University of Melbourne; James McCluskey, **co-senior authors, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity

F.74

Mucosal Associated Invariant T cells Respond in vivo to Riboflavin-derived Ligands and Co-stimulatory Signals
Zhenjun Chen, *, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity; Huimeng Wang, *co-first authors, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity; Criselle Dsouza, University of Melbourne; Alexandra Corbett, **, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity; James McCluskey, **co-senior authors, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity

F.75

THE IMPACT OF CO-INFECTION WITH CITROBACTER RODENTIUM ON MORTALITY AND MORBIDITY DURING EXPERIMENTAL MALARIA INFECTION
Luara Isabela Santos, University of Oxford; Suelen Diniz, UFMG; Ricardo Gazzinelli, UMASS; Lis Antonelli, FIOCRUZ; Kevin Maloy, University of Oxford

F.76

Murine Norovirus Infection is Inhibited in Rag2 Gamma Chain- Deficient Mice after Oral Administration
Mariam B. Gonzalez-Hernandez, PhD, Graduate Program of Immunology, Medical School, University of Michigan; Abimbola O. Kolawole, PhD, Department of Microbiology and Immunology, Medical School, University of Michigan; Holly Turula, BS, University of Michigan; Chenchen Yu, MD, Department of Microbiology and Immunology, Medical School, University of Michigan; Michael D. Elftman, PhD, University of Detroit Mercy School of Dentistry; Christiane E. Wobus, PhD, Department of Microbiology and Immunology, Medical School, University of Michigan

F.77

IFN-γ umpires recovery from mucosal inflammation by regulating macrophage and γδ T cell homeostasis during microbial gut infection
Tamas Dolowschiak, ETH Zurich; Rounak Vyas, Bioinformatics Group, Institute of Molecular Life Sciences, University of Zurich; Anna A. Mueller, Institute of Microbiology, D-BIOL, ETH Zurich; Lynn Pisan, Institute of Microbiology, D-BIOL, ETH Zurich; Boas Felmy, ETH Zurich; Christian von Mering, Bioinformatics Group, Institute of Molecular Life Sciences, University of Zurich; Wolf-Dietrich Hardt, Institute of Microbiology, D-BIOL, ETH Zurich

F.78

Development of Mucosal Candida Colonization and Dissemination Model in Immunodeficient Mice
Chien-Hsiung Pan, National Health Research Institutes; Szu-Hsien Wu, NHRI

F.79

The Colonic Cytokine Environment Found During Brachyspira hyodysenteriae Infection Induces Mucus Changes in a Mucus Secreting, Polarized In Vitro Colonic Mucosal Surface
Macarena Quintana-Hayashi, D.V.M, Ph.D,, Department of Medical Biochemistry and Cell biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Nazanin Navabi, Department of Medical Biochemistry and Cell biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Harvey R. Fernandez, Department of Medical Biochemistry and Cell biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Frank Pasmans, Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University; Freddy Haesebrouck, Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University; Nele De Pauw, Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University; Maxime Mahu, Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University; Filip Boyen, Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University; Sara K. Lindén, Department of Medical Biochemistry and Cell biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg

F.80

Intestinal Microbiota Alters Omental Tumor Growth
Selene Meza-Perez, PhD, University of Alabama at Birmingham, Department of Medicine; Aaron Silva Sanchez, PhD, University of Alabama at Birmingham; Maria de la luz Garcia-Hernandez, PhD, University of Rochester; Uma Mudunuru, University of Alabama at Birmingham; Javier Rangel-Moreno, PhD, URMC-Rochester; Stacey Sinclair, University of Alabama at Birmingham; Trenton R Schoeb, PhD, University of Alabama at Birmingham; Casey T Weaver, PhD, University of Alabama at Birmingham; Troy Randall, PhD, University of Alabama at Birmingham, Department of Medicine

F.81

Suppressor of Cytokine Signaling (SOCS)-1 in the Cell Nucleus – A Regulator of Local Immunity in the Lung?
Jana Zimmer, Dept. of Infectious Diseases, Medical Microbiology and Hygiene; Michael Weitnauer, Dept. of Infectious Diseases, Medical Microbiology and Hygiene; Sabrina Thiele, Dept. of Infectious Diseases, Medical Microbiology and Hygiene; Bernd Arnold, German Cancer Research Center (DKFZ); Günter Küblbeck, German Cancer Research Center (DKFZ); Felix Lasitschka, Institute of Pathology; Lars Lunding, Division of Asthma Mouse Model, Airway Research Center North, Member of the German Center for Lung Research (DZL), Research Center Borstel; Michael Wegmann, Division of Asthma Mouse Model, Airway Research Center North, Member of the German Center for Lung Research (DZL), Research Center Borstel; Alexander Dalpke, MD, Department of infectious disease, University hospital Heidelberg

F.82

Expression of the TGFβ-Activating Integrin α_vβ₈onDendritic cells is Important for Regulation of Human T Cell Responses
Thomas Fenton, University of Manchester; Markus Lehtinen, DuPont Nutrition and Health; Mark Travis, University of Manchester

F.83

Dysregulations of mucosal and systemic immune responses at adulthood after perinatal exposure to bisphenol A (BPA): possible involvement in food adverse reactions and inflammatory diseases
Laurence Guzylack-Piriou, INRA; Sandrine MÃƒÂ©nard, INRA; Yann Malaisé, INRA Toxalim, Research Centre in Food Toxicology, Intestinal Development, Xenobiotics & ImmunoToxicology; Christel Cartier, INRA Toxalim, Research Centre in Food Toxicology, Intestinal Development, Xenobiotics & ImmunoToxicology; Corinne Lencina, INRA Toxalim, Research Centre in Food Toxicology, NeuroGastroenterology & Nutrition; Eric Gaultier, INRA Toxalim, Research Centre in Food Toxicology, Intestinal Development, Xenobiotics & ImmunoToxicology; Eric Houdeau, INRA Toxalim, Research Centre in Food Toxicology, Intestinal Development, Xenobiotics & ImmunoToxicology

F.84

Epithelial E-cadherin and its receptor KLRG1 limit the accumulation of Treg in the gut
Holger Meinicke, MD, University Hospital Freiburg; Anna Bremser, Max Planck Institute of Immunobiology and Epigenetics; Ana Izcue, Centre of Chronic Immunodeficiency

F.85

Bet v 1, a Lipocalin-like Allergen, is Capable of Binding to Siderophore-bound Iron thereby Skewing T-helper Cell Responses
Franziska Roth-Walter, PhD, Messerli Research Institute; Cristina Gomez-Casado, PhD, Biotechnology Department, Center for Plant Biotechnology and Genomics, Technical University of Madrid; Luis F Pacios, PhD, Department of Natural Resources and Systems, ETSI Montes, Technical University of Madrid; Nadine Mothes-Luksch, MD, AllergyCare; Georg A Roth, MD, Department of Anesthesiology, General Intensive Care and Pain Medicine, Medical University of Vienna; Josef Singer, MD PhD, Comparative Immunology and Oncology, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna; Araceli Diaz-Perales, PhD, Biotechnology Department, Center for Plant Biotechnology and Genomics, Technical University of Madrid; Erika Jensen-Jarolim, MD, Comparative Immunology and Oncology, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna

F.86

The Role of Ultraviolet B Light Induced Vitamin Din Gastrointestinal Pathology
Else Bosman, University of British Colombia

F.87

Symbiotic Microbiota Regulates Type 2 Immunity through RORγt⁺ T Cells
Caspar Ohnmacht, Centre of Allergy & Environment (ZAUM), Technical University and Helmholtz Centre Munich; Joo-hong Park, Institut Pasteur; Sascha Cording, Institut Pasteur; James Wing, Immunology Frontier Research Center, Osaka University; Koji Atarashi, RIKEN Center for Integrative Medical Sciences; Yuuki Obata, The University of Tokyo; Valerie Gaboriau-Routhiau, INSERM 1163; Maria Fedoseeva, Centre of Allergy and Environment (ZAUM), Technical University and Helmholtz Centre Munich; Rute Marques, Institut Pasteur; Meinrad Busslinger, Research Institute of Molecular Pathology; Nadine Cerf-Bensussan, INSERM, U989, and Institut IMAGINE, Université Paris Descartes-Sorbonne Paris Cité; David Voehringer, University Clinic Erlangen and Friedrich-Alexander University Erlangen-Nuremberg; Koji Hase, The University of Tokyo; Kenya Honda, RIKEN Center for Integrative Medical Sciences; Shimon Sakaguchi, M.D., Ph.D., Immunology Frontier Research Center, Osaka University; Gerard Eberl, PhD, Institut Pasteur

F.88

Effect of Low Level Laser on sIgA and Lysozyme Levels in Saliva after Third Molars Surgery
Stepan Podzimek, Charles University, First Faculty of Medicine and GUH, School of Dental Medicine; Tatjana Dostalova, Charles University, 2nd Faculty of Medicine and University Hospital in Motol, Department of Stomatology; Veronika Kroulikova, Charles University, 2nd Faculty of Medicine and University Hospital in Motol, Department of Stomatology; Helena Jelinkova, Czech Technical University in Prague, Faculty of Nuclear Sciences and Physical Engineering

F.89

The Regulation of Oral Tolerance by Intestinal Macrophages Utilizes Two Distinct Pathways Involving either CD11b or CX3CR1
Anika Schridde, Institute of Immunology, Hannover Medical School; Vuk Cerovic, RWTH Aachen University; Milas Ugur, Institute of Molecular Medicine, University Hospital RWTH Aachen; Oliver Pabst, MD, Institute of Molecular Medicine, University Hospital RWTH Aachen

F.90

Invariant natural killer T lymphocytes promote the development of intestinal tumors
Susanna Cardell, PhD, University of Gothenburg; Ying Wang, University of Gothenburg; Saikiran Sadimbi, PhD, Karolinska Institute; Linda Löfbom, University of Gothenburg

F.91

Commensal Escherichia coli Induces Systemic Antigen-specific Tolerance
Eveline Bennek, Department of Internal Medicine III, University Hospital RWTH Aachen; Ana Mandic, Uniklinik Aachen; Silvia Roubrocks, Department of Internal Medicine III, University Hospital RWTH Aachen; Julien Verdier, PhD, Department of Internal Medicine III, University Hospital RWTH Aachen; Thomas Kufer, PhD, Institut of Immunology, University of Hohenheim; Christian Liedtke, PhD, Department of Internal Medicine III, University Hospital RWTH Aachen; Christian Trautwein, MD, Department of Internal Medicine III, University Hospital RWTH Aachen; Gernot Sellge, MD, PhD, University Hospital RWTH Aachen

F.92

CBirTox Selectively Induces CD4⁺Foxp3⁺ T Cells to Microbiota Flagellin
Katie Alexander, University of Alabama at Birmingham; Jannet Katz, DDS, PhD, University of Alabama at Birmingham; Charles Elson, MD, University of Alabama at Birmingham

F.93

Selective regulation in expression of co-inhibitory molecule B7-H1/PD-L1 on masticatory mucosae
Siwen Kang, Tokyo Medical and Dental University (TMDU); Tatsukuni Ohno, Tokyo Medical and Dental University (TMDU); Shigenori Nagai, Tokyo Medical and Dental University (TMDU); Miyuki Azuma, Tokyo Medical and Dental University (TMDU)

F.94

The effects and mechanism of tonsil derived mesenchymal stem cells in a mouse model of eosinophilic rhinosinusitis with nasal polyp
Ji-Hun Mo, MD, PhD, Dept of otorhinolaryngology Dankook University; Ramachandran Samivel, PhD, Dank University; Yong Min Kim, MD, PhD, Chunggna national university

F.95

ORAL ADMINISTRATION of LACTIC ACID BACTERIA PREVENTS STEATOSIS in a MURINE MODEL for NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Noriko M Tsuji, PhD, National Inst. Advanced Industrial Science and Technology (AIST); Ami Satou, Ms, National Inst. Advanced Industrial Science and Technology (AIST); Yohei Watanabe, Ms, National Inst. Advanced Industrial Science and Technology (AIST); Hiromi Kimoto, PhD, NARO Institute of Livestock and Grassland Science; Tadashi Nemoto, PhD, National Inst. Advanced Industrial Science and Technology (AIST); Shigeru Kakuta, PhD, DVM, Graduate School of Agricultural and Life Sciences, The University of Tokyo; Kazuhiro Hirayama, PhD, DVM, Graduate School of Agricultural and Life Sciences, The University of Tokyo; Tatsuya Kanto, MD, National Center for Global Health and Medicine

F.96

Oral dendritic cells present sublingual antigen and induce regulatory T cells in the draining lymph nodes
Yukinori Tanaka, Tohoku University Graduate School of Dentistry; Hiroyuki Nagashima, Tohoku University Graduate School of Medicine; Lu Lu, Tohoku University Graduate School of Dentistry; Akane Ozaki, Tohoku University Graduate School of Dentistry; Yumi Morita, Tohoku University Graduate School of Dentistry; Satoshi Fukumoto, Tohoku University Graduate School of Dentistry; Naoto Ishii, Tohoku University Graduate School of Medicine; Shunji Sugawara, Tohoku University Graduate School of Dentistry

F.97

ORAL ADMINISTRATION OF NEITHER HSP65-PRODUCING NOR IL-10-PRODUCING LACTOCOCCUS LACTIS AMELIORATES OBESITY-RELATED METABOLIC DISORDERS
Andrezza Santiago, UFMG; Ester Pinter Cordeiro, Universidade Federal de Minas Gerais - UFMG; Mariana Camila Gonçalves Miranda, MD, Universidade Federal de Minas Gerais - UFMG; Luiz Roberto Alves Oliveira Junior, PhD, Universidade Federal de Minas Gerais - UFMG; Tatiani Uceli Maioli, PhD, Universidade Federal de Minas Gerais - UFMG; Ana Maria Caetano de Faria, PhD, Universidade Federal de Minas Gerais - UFMG

F.98

Development of Immunization Protocols to Induce Integral (Systemic and Mucosal) Immune Response
Marco Vega-Lopez, PhD, Centro de Investigacion y de Estudios Avanzados del IPN, Mexico; Carmen Ramirez-Estudillo, BSc., Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Infectómica y Patogénesis Molecular, Laboratorio de Inmunobiología de las Mucosas. mavega@cinvestav.mx; Gabriela Alvarado-Cesar, DVM, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Infectómica y Patogénesis Molecular, Laboratorio de Inmunobiología de las Mucosas. mavega@cinvestav.mx; Carlos Garcia-Ruiz, BSc, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Infectómica y Patogénesis Molecular, Laboratorio de Inmunobiología de las Mucosas. mavega@cinvestav.mx; Ivan Salinas, BSc, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Infectómica y Patogénesis Molecular, Laboratorio de Inmunobiología de las Mucosas. mavega@cinvestav.mx; Edgar Guzman-Bautista, MSc, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Infectómica y Patogénesis Molecular, Laboratorio de Inmunobiología de las Mucosas. mavega@cinvestav.mx; Alicia Gama, BSc, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Infectómica y Patogénesis Molecular, Laboratorio de Inmunobiología de las Mucosas. mavega@cinvestav.mx

F.99

Flagellin is a Strong Vaginal Adjuvant for Therapeutic Vaccine in Genital Cancer
Joon Haeng Rhee, MD, PhD, Chonnam National University; Shee Eun Lee, PhD, Clinical Vaccine R&D Center; Seol Hee Hong, MS, Clinical Vaccine R&D Center; Vivek Verma, PhD, Clinical Vaccine R&D Center; Kwangjoon Jeong, MD, PhD, Clinical Vaccine R&D Center; In-Kyu Park, PhD, Clinical Vaccine R&D Center; Jung Joon Min, MD, PhD, Clinical Vaccine R&D Center; Young Chul Sung, PhD, POSTECH

F.100

Bacterial Outer Membrane Vesicles (OMVS) Provide Broad and Immediate Protection against Influenza Infection
Doo-Jin Kim, PhD, Korea Research Institute of Bioscience and Biotechnology; Eun-Hye Bae, PhD, Korea Research Institute of Bioscience and Biotechnology; Sang Hwan Seo, PhD, Korea Research Institute of Bioscience and Biotechnology; Tae-Young Lee, PhD, Korea Research Institute of Bioscience and Biotechnology; Chang-Ung Kim, Korea Research Institute of Bioscience and Biotechnology; Sang-Ho Lee, Korea Research Institute of Bioscience and Biotechnology; Min-Joo Yeom, Korea Research Institute of Bioscience and Biotechnology; Daesub Song, PhD, Korea Research Institute of Bioscience and Biotechnology; Sun-Woo Yoon, PhD, Korea Research Institute of Bioscience and Biotechnology; Sang-Hyun Kim, PhD, Korea Research Institute of Bioscience and Biotechnology

F.101

GINGIVAL MUCOSA as an ALTERNATIVE VACCINATION ROUTE: IMPLICATIONS for ELDERLY VACCINATION
Marni Cueno, PhD, Nihon University School of Dentistry; Muneaki Tamura, DDS, PhD, Nihon University School of Dentistry; Kuniyasu Ochiai, DVM, PhD, Nihon University School of Dentistry

F.102

New Chimeric NOD2/TLR2 Adjuvant Induces Mucosal Immune Response After Subcutaneous Administration.
Alice Gutjahr, UMR5305 CNRS; Vincent Pavot, Groupe Immunité des Muqueuses et Agents Pathogènes, INSERM; Gérard Tiraby, InvivoGen; Eric Perouzel, InvivoGen; Thierry Lioux, InvivoGen; Fabienne Vernejoul, InvivoGen; Stéphane Paul, Groupe Immunité des Muqueuses et Agents Pathogènes, INSERM; Bernard Verrier, Laboratoire de Biologie Tissulaire et d’Ingénierie Thérapeutique UMR5305 - CNRS

F.103

Oral Immunization with Lactococcus lactis Expressing EspB Enhances Clearance of Escherichia coli O157:H7 in two Murine Infection Models
Eric Cox, DVM, PhD, Lab of Immunology, Ghent University; Bakr Ahmed, DVM, PhD, Lab of Immunology, Ghent University; Michaela Loos, PhD, DeLaval; Daisy Vanrompay, DVM, PhD, Lab of Immunology and Animal Biotechnology, Ghent University

F.104

TSLP-responsive mucosal DCs are critical for the induction of pneumococcal vaccine antigen-specific IgA response in nasal immunization.
Sunyi Joo, The University of Tokyo; Yoshiko Fukuyama, The University of Tokyo; Yoshikazu Yuki, The Institute of Medical Science, Univ of Tokyo; Yosuke Kurashima, The University of Tokyo; Steven Ziegler, Benaroya Research Institute; Eun Jeong Park, The University of Tokyo; Hiroshi Kiyono, The University of Tokyo

F.105

INTERLEUKIN-22 IS A CRITICAL MEDIATOR OF VACCINE-INDUCED REDUCTION OF HELICOBACTER INFECTION IN THE MOUSE MODEL
Mati Moyat, CHUV; Hanifa Bouzourene, MD, UNISciences, University of Lausanne, UniLabs; Wenjun Ouyang, PhD, 3Department of Immunology, Genentech; Jean-Christophe Renauld, Pr, Ludwig Institute for Cancer Research; Dominique Velin, CHUV

F.106

ROLE OF INFLAMMATORY MONOCYTES IN VACCINE-INDUCED REDUCTION OF HELICOBACTER INFECTION
Mati Moyat, CHUV; Matthias Mack, Universitätsklinikum Regensburg Innere Medizin II –Nephrologie; Hanifa Bouzourene, MD, UNISciences, University of Lausanne, UniLabs; Dominique Velin, CHUV

F.107

The Role of Microbiota in CT Induction of Intestinal Homeostatic Th17 Cells
Qing Zhao, University of Alabama at Birmingham; Trenton R Schoeb, PhD, University of Alabama at Birmingham; Charles Elson, MD, University of Alabama at Birmingham

F.108

Cathelicidin LL-37 constructs immune-stimulatory microenvironment in mucosal immune system
Sae-Hae Kim, Chonbuk National University; Yu Na Kim, Department of Bioactive Material Sciences and Research Center of Bioactive Materials, Chonbuk National University; Ha-Yan Lee, Department of Bioactive Material Sciences and Research Center of Bioactive Materials, Chonbuk National University; Jisang Park, Department of Bioactive Material Sciences and Research Center of Bioactive Materials, Chonbuk National University; Yong-Suk Jang, PhD, Chonbuk National Univ

F.109

Non-invasive universal influenza vaccine based on adenovirus vector
Eun Hye Kim, Ph.D, Viral Immunology Laboratory, International Vaccine Institute; Hae-Jung Park, Viral Immunology Laboratory, International Vaccine Institute; Gye-Yeong Han, Viral Immunology Laboratory, International Vaccine Institute; Man-Ki Song, Ph.D., Viral Immunology Laboratory, International Vaccine Institute; Alexander Pereboev, Ph.D., Gene Therapy Center, University of Alabama; Jeong S. Hong, Ph.D., Department of Cell Biology, University of Alabama; Jun Chang, Ph.D., Graduate School of Pharmaceutical Sciences, Ewha Womans University; Young-Ho Byun, Department of Biotechnology and Vaccine Translational Research Center, Yonsei University; Baik Lin Seong, Ph.D., Department of Biotechnology and Vaccine Translational Research Center, Yonsei University; Huan H. Nguyen, Ph.D, Viral Immunology Laboratory, International Vaccine Institute

F.110

Assessment of immune responses in mice after intranasal immunization using outer membrane vesicles derived from 3 different Gram-negative pathogens
Ryoma Nakao, National Institute of Infectious Diseases; Nozomu Obana, University of Tsukuba; Kyoko Nagayama, University of Tsukuba; Nobuhiko Nomura, University of Tsukuba; Makoto Ohnishi, National Institute of Infectious Diseases; Hidenobu Senpuku, National Institute of Infectious Diseases

F.111

Parasite Derived Immunomodulatory Molecules for Prevention and Therapy of Allergy
Mirjana Drinic, Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna; Irma Schabussova, Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna; Angelika Wagner, Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna; Ursula Wiedermann-Schmidt, Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna; Anja Joachim, ² University of Veterinary Medicine; Bärbel Ruttkowski, ² University of Veterinary Medicine

F.112

Pathways to Antigen Expression after Oral Delivery of an Adenovirus-Based Vaccine
Julien Revaud, Ecole Nationale Vétérinaire d'Alfort; Yves Unterfinger, Ecole Nationale Vétérinaire d'Alfort; Sandra Galea, Ecole Nationale Vétérinaire d'Alfort; Muhammad Suleman, PhD, DVM, Ecole Nationale Vétérinaire d'Alfort; Jennifer Maye, Seppic; Nicolas Versillé, PhD, Seppic; Bernard Klonjkowski, PhD, Ecole Nationale Vétérinaire d'Alfort; Nathalie Cordonnier, PhD, DVM, Ecole Nationale Vétérinaire d'Alfort; Blaise Corthésy, PhD, Université de Lausanne; Juliette Ben Arous, PhD, Seppic; Jennifer Richardson, PhD, Ecole Nationale Vétérinaire d'Alfort

F.113

RECOMBINANT ATTENUATED SALMONELLA VACCINE (RASV) VACCINATION in NEONATAL MICE is ENHANCED by ANTIGEN SPECIFIC ANTIBODIES
Stephen Forbes, Arizona State University; Jacquelyn Kilbourne, Arizona State University; Roy Curtiss III, Arizona State University

F.114

The Role of Nanoparticle Surface Charge in the Generation of Mucosal and Systemic Antibody Responses Following Pulmonary Delivery
Catherine Fromen, PhD, University of Michigan; Gregory Robbins, PhD, University of North Carolina at Chapel Hill; Tojan Rahhal, University of North Carolina at Chapel Hill; Marc Kai, PhD, North Carolina State University; Tammy Shen, PhD, University of North Carolina at Chapel Hill; J. Christopher Luft, PhD, University of North Carolina at Chapel Hill; Jenny Ting, PhD, University of North Carolina at Chapel Hill; Joseph DeSimone, PhD, North Carolina State University

F.115

Targeting Yeast Ghosts to Epithelial CD13 Promotes Mucosal Immunity
Bert Devriendt, PhD, University of Ghent; Kim Baert, Lab of Immunology, Ghent University; Vesna Melkebeek, PhD, Lab of Immunology, Ghent University; Martine De Vos, MD, PhD, Department of Gastroenterology, Ghent University; Eric Cox, DVM, PhD, Lab of Immunology, Ghent University

F.117

DIETARY RETINOL IS REQUIRED for BOTH ORAL and INTRANASAL ANTILEISHMANIAL VACCINE EFFICACY
Izabella Bezerra, MSc, Federal University of Rio de Janeiro; Julia Azevedo, Universidade Federal do Rio de Janeiro; Bartira Rossi-Bergmann, PhD, Universidade Federal do Rio de Janeiro

F.118

A Germinal Center Immunomodulator: The CTA1-DD Adjuvant Acts on Follicular Dendritic Cells and Potentiates Follicular T Helper Cell Functions
Sophie Schussek, MIVAC, University of Gothenburg; Johan Mattsson, PhD, Astra Zeneca; Karin Schön, University of Gothenburg; Nils Lycke, Prof., University of Gothenburg

F.119

Oral immunization induces an effective mucosal immune response that protects mice against intravaginal HSV-2 challenge
Peter Mulvey, Queensland University of Technology; John Aaskov, Professor, Queensland University of Technology; Frank Aldwell, Doctor, University of Otago; Kenneth Beagley, PhD, Queensland Univ of Technology

F.120

Functional Significance of Antibody Isotype in Protection Against HIV
Morgane Bomsel, PhD, Institut Cohin, CNRS, INSERM; Daniela Tudor, PhD, INSERM U.1016; Marwa Khamassi, Master, Institut Cochin, CNRS, INSERM; Danae David, Master, Institut Cochin, CNRS, INSERM; Pierre Tuffery, PhD, Molécules Thérapeutiques in silico (MTi), Université Paris7

F.121

New vaccination strategy against Helicobacter pylori
Florian Anderl, ImevaX GmbH; Maria Andree, ImevaX GmbH; Kathrin Straubinger, ImevaX GmbH; Markus Gerhard, ImevaX GmbH

F.122

Self-Adjuvanting Virus-Like Particles for Sublingual Vaccination against Group A Streptococcus Elicit Protective Immunity in Systemic and Mucosal Sites
IL Gyu Kong, Department of Otorhinolaryngology-Head & Neck Surgery, Hallym University Sacred Heart Hospital; Arjun Seth, The University of Queensland, Australian Institute for Bioengineering and Nanotechnology; Jin-Young Yang, University of Ulsan College of Medicine/Asan Medical Center; Su-Hyun Lee, University of Ulsan College of Medicine/Asan Medical Center; Yong-Soo Lee, University of Ulsan College of Medicine/Asan Medical Center; Yeji Kim, University of Ulsan College of Medicine/Asan Medical Center; Nani Wibowo, The University of Queensland, Australian Institute for Bioengineering and Nanotechnology; Mi-Na Kweon, Ph.D, University of Ulsan College of Medicine/Asan Medical Center

F.123

A NOVEL NASAL MULTIPLEX DNA-GOLD NANOROD VACCINE against HUMAN PAPILLOMAVIRUS INFECTION
Wenqin Li, PhD, SIPBS, University of Strathclyde

F.124

Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection Against Influenza A/PR/8 Virus Infection Under Suboptimal Treatment with Oseltamivir.
Eun Hye Hong, Kangwon national university; Bo-Eun Kwon, Kangwon National University; Sang-Gu Yeo, Korea Centers for Diseases Control and Prevention; Hyun-jeong Ko, Kangwon National University

F.125

Investigating the Interaction of SP-A and SP-D with Respiratory Syncytial Virus in Human Bronchial Epithelial Cells.
Alastair Watson, MRes, University of Southampton; C. Mirella Spalluto, PhD, Universiy of Southampton; Karl J Staples, PhD, Universiy of Southampton; Tom M.A. Wilkinson, MA, MBBS, MRCP, PhD, Universiy of Southampton; Jens Madsen, PhD, Universiy of Southampton; Howard W Clark, BA MA MB BChir MA MD (Cantab) MA DPhil (Oxon) MRCP MRCPCH, Universiy of Southampton

F.126

Pulmonary Cellular Immune Responses to RSV infection is Associated with Concomitant Lung Damage and Differential Lymphocytic and Macrophage Activation in Different Age Groups of Hosts
Kainath Durre, MS, Touro University Nevada College of Osteopathic Medicine; Omar Qureshi, Touro University Nevada College of Osteopathic Medicine; Mahboob Qureshi, MD, PhD, Touro University Nevada College of Osteopathic Medicine

F.127

The Role of Cdcs1 and Naive T Cell Subsets in the Onset of Colitis
Inga Bruesch, Hannover Medical School, Institute for Laboratory Animal Science; Manuela Buettner, Hannover Medical School, Institute for Laboratory Animal Science; Andé Bleich, Hannover Medical School, Institute for Laboratory Animal Science

F.128

The intestinal epithelial cells and toll-like receptors TLR-2 and TLR-4 involvement in immune modulatory effect of AHCC
Yosuke Hirayama, PhD, Amino Up Chemical; Jean-Francois Mallet, Faculty of Medicine, University of Ottawa; Emilie Graham, Faculty of Health Sciences, University of Ottawa; Barry W Ritz, PhD, College of Nursing and Health Professions, Drexel University; Chantal Matar, PhD, Faculty of Health Sciences, University of Ottawa; Kohei Homma, PhD, Amino Up Chemical; Hajime Fujii, Amino Up Checmical Co.